AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

iTBS for Increased Appetite Induced by Antipsychotics

RecruitingNAAges 18 Years - 40 YearsAllCentral South University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Antipsychotics are prone to cause metabolic side effects, including weight gain, hyperglycemia, insulin resistance, hyperlipidemia and so on, leading to a 2-3 times higher risk of death in patients with schizophrenia compared to healthy people. Conventional high-frequency rTMS have been used to treat people with obesity and showed certain effectiveness. However, studies involving schizophrenia patients and intermittent theta burst (iTBS) mode are rarely seen. The goal of this clinical trial is to evaluate the efficacy and safety of iTBS on ameliorating increased appetite induced by antipsychotics in people with schizophrenia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age between 18-40 years old; 2. Meeting the diagnostic criteria for schizophrenia in DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition); 3. BMI โ‰ฅ 25kg/m 2 or over 10% weight gain after taking antipsychotics in the last year; 4. Not receiving TMS therapy in the past month; 5. Using no more than two antipsychotic medications (including olanzapine, haloperidol, amisulpride, asenapine, risperidone, paliperidone, clozapine, quetiapine, iloperidone, chlorpromazine, sertindole, zotepine), not using antidepressants, mood stabilizers and other drugs, but allowing short-term use of benzodiazepines, benzhexol and propranolol; 6. Signing written informed consents voluntarily. Exclusion Criteria: 1. Other severe mental illnesses, mental retardation, dementia and severe cognitive impairment according to diagnostic criteria of ICD-10 or DSM-5; 2. Abnormal brain structure or function owing to any major physical disease, neurological disease, traumatic brain injury, etc.; 3. Metallic implants, pacemakers, epilepsy history or other contraindications of TMS; 4. Suicidal thoughts or behaviors; 5. Alcohol or substance abuse; 6. Pregnant or lactating women; 7. Other contraindications of MRI; 8. Receiving regular MECT, or weight-loss therapy in the latest month; 9. Other abnormal examination results considered to be inappropriate for inclusion by researchers.
๐Ÿ’Š

What it tests

  • Active iTBS
  • Sham iTBS
๐Ÿ“

Where

2 sites
Central South University
Changsha, China
The Second People's Hospital of Dali Bai Autonomous Prefecture
Dali, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy